西安诺和达生物科技有限公司
+86 13662665103 Mon–Fri, 09:00–18:00 GMT+8 Contact Us sales@nhdbio.com
Lot-document scope confirmed before quotation · Research use only
  • Specification Review
  • Lot Documents on Request
  • Business Support · Xi’an
  • Destination Eligibility Confirmed
西安诺和达生物科技有限公司

Quote list

Review quantities before sending your request.

View full quote listContinue browsing productsThis is an enquiry list, not a checkout. No payment is taken.
 Request an Account

Tissue-repair research comparison

BPC-157 vs BPC-157 + TB-500 Blend

A preclinical evidence comparison covering material identity, the 2026 rat Achilles-tendon experiment and why combination findings do not establish human recovery outcomes.

Internal source review2026-10-135 linked sourcesReview policy & commercial disclosure

Editorial answer

The short answer

The best directly matching comparison is a small exploratory rat study. It reported no additive benefit for the combination over either agent alone, and it provides no controlled human efficacy or safety evidence.

Research and evidence interpretation only. No usage or dosing guidance.

Structured comparison

Compare like with like

Every difference includes an interpretation note so a molecular or protocol distinction is not converted into a marketing claim.

Swipe horizontally to compare every column

QuestionBPC-157BPC-157 + TB-500 BlendEditorial interpretation
Material definitionSingle synthetic 15-amino-acid peptideTwo-component mixture; TB-500 naming may refer to an acetylated thymosin-β4 fragment or be used inconsistentlyA blend requires component identity and quantitative ratio controls.
Direct comparative evidenceIncluded as one arm in a 32-rat Achilles-tendon studyCombination arm included in the same studyEight rats per group; intraperitoneal exposure for four weeks.
Biomechanical resultMaximum load was numerically higher than control but not statistically significantThe abstract did not report an additive biomechanical advantageTB-500 alone reached statistical significance for maximum load in this experiment.
Histology resultNumerically lower total scores without significance for the reported total scoresLower total Movin score versus control (p=0.040)Combination did not confer additional benefit over either agent alone.
Human evidenceNo adequate controlled human efficacy evidence identifiedNo controlled human combination evidence identifiedAnimal tendon findings cannot establish human recovery or dosing.

Evidence cards

What the linked records actually report

Findings remain attached to the study population, experimental model and source type.

Direct rat comparison

Thirty-two male rats were randomized to control, BPC-157, TB-500 or the combination for four weeks after Achilles transection and repair.

Exploratory animal model with eight animals per group.Open source ↗
Combination result

The authors reported no additional benefit from combined BPC-157 and TB-500 compared with either agent alone.

The finding applies only to the stated rat model, exposure and endpoints.Open source ↗
Identity safeguard

An analytical publication identified TB-500 as an N-terminal acetylated thymosin-β4 17–23 fragment in a seized product.

Other catalogs may use TB-500 differently; the supplied sequence must be documented.Open source ↗

Translation boundary

What this comparison cannot establish

  • That the blend is superior to BPC-157 alone.
  • That rat histology predicts human injury recovery.
  • That a trade-style TB-500 name defines the sequence, ratio, purity or sterility of a catalog blend.

Sources

References used for this comparison

Search all related evidence →
  1. 01

    Effects of BPC-157 and TB-500 on Achilles tendon healing in rats

    Biçer O, et al. Jt Dis Relat Surg. 2026;37:822–837. PMID 42542926.

    Randomized rat study
  2. 02

    Emerging Use of BPC-157 in Orthopaedic Sports Medicine

    Systematic review. 2025. PMID 40756949.

    Systematic review
  3. 03Analytical identity
  4. 04Clinical evidence review
  5. 05

    Care and handling of peptides

    Care and handling of peptides

Editorial analysis

Read the product-specific source reviews

These articles expand individual identity, trial and evidence questions without changing the comparison conclusions above.

Comparison FAQ

Questions this page is designed to answer

Did the 2026 rat study show that the combination was better?

No. The authors explicitly reported no additional benefit for combined BPC-157 and TB-500 compared with either agent alone.

Are there controlled human trials of the exact blend?

No adequate controlled human trial of the exact catalog combination was identified for this review.

Continue researching

Open the product dossiers or search the full evidence set.

BPC-157 dossierBPC-157 + TB-500 Blend dossierResearch glossaryEvidence database

A peptide blend says 10 mg. How much of each component is in it?

"10 mg mixed peptide" may only give the total amount. To know how much of each component is present, you need to look at the composition and ratios, and confirm what unit the ratios are written in.

First read clearly which kind of amount the label states

A total amount is the number you get by adding up the amounts of each component; individual component amounts should be listed separately. If the label only says "Blend 10 mg" with no component amounts, you cannot assume each makes up 5 mg, nor can you count each one as 10 mg.

Here you also need to confirm the basis of the stated amount: total mass of the lyophilized material, the stated amount of each component, or content measured by some method. Different bases cannot be freely interchanged.

Work through it with a hypothetical label

Suppose a vial of mixture clearly states: Component A is 6 mg, Component B is 4 mg, total 10 mg. Based on this label, the mass proportion of A is 60%, and B is 40%. If prepared into a final solution of 2 mL, calculated by the stated amounts, A is 3 mg/mL, B is 2 mg/mL, and the total concentration is 5 mg/mL.

All of the above is hypothetical teaching data, not the batch result of any NHD mixed product, and it does not prove actual dissolution or content. Numbers can only be used this way when the label composition and the basis of the amounts are clear.

Mass proportion and molecular count proportion are not the same thing

Two components have different molar masses, so the same mass may contain different numbers of molecules. Therefore "half by mass each" does not equal "half by molecular count each." If an experiment needs an equimolar ratio, calculate separately using each component's mass and molar mass.

If the exact identity, modification or form of a component is unclear, confirm the material first, then do the molar conversion. Do not randomly pick a molecular weight from the internet just to get a number.

When you see a BPC-157 and TB-500 mixed material, what else should you ask?

Confirm each component's identity, total amount, each component amount, and packaging. The naming usage of TB-500 may involve different records, and the full structure cannot be inferred from the mixture name; a single-component BPC-157 page also cannot serve as a complete description of the whole mixture.

Experimental results for a mixture need suitable controls. If you want to determine what a certain component contributes, a mixture group and a blank group alone are usually not enough; you should also consider single-component comparisons and other comparisons based on the research purpose.

Hypothetical label amount breakdown
Component AStated amount: 6 mgStated amount concentration at final 2 mL: 3 mg/mL
Component BStated amount: 4 mgStated amount concentration at final 2 mL: 2 mg/mL
TotalStated amount: 10 mgStated amount concentration at final 2 mL: 5 mg/mL
Teaching summary. Check the explanation and original sources; this is not a to-scale molecular model or a product test result.
Hypothetical label amount breakdown
ItemStated amountStated amount concentration at final 2 mL
Component A6 mg3 mg/mL
Component B4 mg2 mg/mL
Total10 mg5 mg/mL
Try to judge for yourself: if you only see "total amount 10 mg," can you calculate how much A and B each contain?

No, you must first obtain the component amounts or a clear composition ratio and the unit basis for it.

Original sources and further reading

Sources checked on 2026-10-13. Findings apply to the models and materials studied. Batch quality requires records for the actual batch.

Related research materials

BPC-157View material identity, specifications, and packaging; documentation needs can be raised with an inquiry.BPC-157 + TB-500 BlendView material identity, specifications, and packaging; documentation needs can be raised with an inquiry.

Inquire about specifications, quantities and required documentation